Patient Acceptability of Autonomous Telemedicine
Patient Acceptability of the Use of an Autonomous Telephone System for the Delivery of Clinical Follow-up Conversations After Cataract Surgery
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Patients will have an automated call supervised by a human clinician to check how they are after uncomplicated cataract surgery as part of their standard of care. The study aims to evaluate the acceptability of this system through a net promoter score and for a subsection of patients using a qualitative interview.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2021
CompletedFirst Posted
Study publicly available on registry
May 13, 2021
CompletedStudy Start
First participant enrolled
May 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedMay 13, 2021
May 1, 2021
2 months
April 29, 2021
May 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
A score out of 10 rating the autonomous system
The patient will score the autonomous system out of 10 and a subsection of patients will have qualitative interviews.
It is anticipated the study will occur over 3 months
Interventions
This study assess acceptability of autonomous conversation as part of cataract surgery follow up.
Eligibility Criteria
Patients undergoing uncomplicated cataract surgery who are suitable for telephone follow up
You may qualify if:
- Routine, first or second eye cataract surgery with intraocular lens implantation without complications.
- Above the age of 16.
- Capacity to give consent
- Access to a phone number.
- Satisfactory command of English for a phone-based consultation.
You may not qualify if:
- Combined glaucoma surgery
- Retinal or glaucoma laser treatment
- Corneal dystrophy or grafts
- Combined vitreoretinal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ufonialead
- Buckinghamshire Healthcare NHS Trustcollaborator
- Innovate UKcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guy Mole, BSc MBBS MSc
Ufonia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2021
First Posted
May 13, 2021
Study Start
May 24, 2021
Primary Completion
July 31, 2021
Study Completion
July 31, 2021
Last Updated
May 13, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- The study findings will be submitted to a peer review journal within 6 months of study completion.
- Access Criteria
- This will likely be an open source journal
The researcher undertaking the qualitative interviews will get access to the patient identifier for those who have consented to take part in the interview so that they can access their contact details from the hospital record.